Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

C4X Discovery Holdings Plc (C4XD.LN)

C4X Discovery Holdings Plc (C4XD.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

C4X Discovery Holdings Plc 53 Portland Street Manchester One Manchester M1 3LD GBR

https://www.c4xdiscovery.com P: 161-235-5085

Description:

C4X Discovery Holdings PLC is a drug discovery and development company. It has various proprietary and synergistic software platforms Taxonomy3, Conformetrix, and 4Sight. Taxonomy3 is a novel in silico platform technology that utilizes proprietary ground-breaking mathematical algorithms to perform complex multivariate analysis of genetic data. Conformetrix enables rational, accelerated 4D structural drug design using experimental data rather than theoretical data. The 4Sight allows its research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules.

Key Statistics

Overview:

Market Capitalization, $K 23,772
Shares Outstanding, K 252,227
Annual Sales, $ 1,710 K
Annual Net Income, $ -11,111 K
% of Insider Shareholders 1.44%
% of Institutional Shareholders 30.47%

Growth:

1-Year Return -20.53%
3-Year Return -71.08%
5-Year Return -78.38%
5-Year Revenue Growth -24.70%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm 0.04
Dividend Payout Ratio 0.00%

C4XD.LN Ratios

Ratio
Price/Earnings ttm 2.25
Price/Earnings forward N/A
Return-on-Equity % 55.38%
Return-on-Assets % 50.37%
Profit Margin % -649.77%
Debt/Equity 0.01
Price/Sales 0.97
Price/Book 0.97
Book Value/Share 0.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar